You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nerlynx

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Toronto, Ontario, Canada
    University Health Network: Princess Margaret Cancer Centre
Oct 31, 2022

Treatment Patterns of Neratinib in HER2+ EBC in China

Not yet recruiting
  • Breast Cancer
  • Shanghai, China
    Medical Affair
Aug 4, 2022

HER2 Amplified Breast Cancer Trial in Lisboa (Neratinib, Capecitabine, Loperamide)

Completed
  • HER2 Amplified Breast Cancer
  • Lisboa, Portugal
    Hospital CUF Descobertas
Apr 4, 2022

Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

Terminated
  • Metastatic Prostate Adenocarcinoma
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jul 18, 2022

Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

Recruiting
  • Solid Tumor, Adult
  • Richmond, Virginia
    Virginia Commonwealth University Massey Cancer Center
Mar 2, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • (no location specified)
Aug 5, 2022

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Brussels, Belgium
  • +56 more
Nov 7, 2022

Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Anaheim, California
  • +47 more
Mar 28, 2022

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations Trial in Worldwide (Neratinib, Fulvestrant, Trastuzumab)

Active, not recruiting
  • Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
  • Birmingham, Alabama
  • +59 more
Mar 3, 2022

Early Stage HER2+ Breast Cancer Trial in Worldwide (Neratinib, Loperamide, Colestipol)

Completed
Has Results
  • Early Stage HER2+ Breast Cancer
  • Birmingham, Alabama
  • +57 more
Apr 12, 2022

Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Vinorelbine)

Completed
Has Results
  • Advanced Malignant Solid Tumors
  • Shizuoka, Japan
  • +1 more
Apr 24, 2018

Breast Cancer Trial in Worldwide (Temsirolimus, Neratinib)

Completed
Has Results
  • Breast Cancer
  • Goodyear, Arizona
  • +11 more
Aug 29, 2018

HER2+ Metastatic Breast Cancer (MBC) Trial in Worldwide (neratinib, capecitabine, lapatinib)

Completed
Has Results
  • HER2+ Metastatic Breast Cancer (MBC)
  • Chandler, Arizona
  • +251 more
May 18, 2021

HER2-mutant NSCLC Trial in France, United States (neratinib, temsirolimus)

Completed
Has Results
  • HER2-mutant Non-Small Cell Lung Cancer
  • Duarte, California
  • +20 more
May 31, 2018

Breast Tumors, Tumors Trial in Worldwide (neratinib)

Completed
Has Results
  • Breast Neoplasms
  • Neoplasms
  • Aurora, Colorado
  • +32 more
Aug 10, 2018

Breast Cancer, Advanced Malignant Solid Tumors Trial in Worldwide (neratinib, vinorelbine)

Completed
Has Results
  • Breast Cancer
  • Advanced Malignant Solid Tumors
  • Fayetteville, Arkansas
  • +34 more
Jul 11, 2018

Advanced Breast Cancer Trial in Worldwide (HKI-272, trastuzumab)

Completed
Has Results
  • Advanced Breast Cancer
  • Duarte, California
  • +13 more
Jun 26, 2018

Tumors Trial in Koto, Shizuoka (neratinib)

Completed
Has Results
  • Tumors
  • Koto, Tokyo, Japan
  • +1 more
Aug 15, 2018